| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |